Q-POC SARS-CoV-2 Assay COVID-19 Clinical Evaluation

NACompletedINTERVENTIONAL
Enrollment

877

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

May 17, 2023

Study Completion Date

May 17, 2023

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

RT-PCR Test

High sensitivity RT-PCR COVID-19 Test. A healthcare professional will take a sample per subject for the comparator test, following the manufacturer's Instructions For Use (IFU) in one nostril.

DIAGNOSTIC_TEST

Real-time PCR Test

Mid-turbinate nasal swab samples will be taken from the opposite nostril that was not swabbed for the comparator sample using Copan FLOQ swabs and placed into MSwab buffer. In instances where opposite nostrils cannot be swabbed for both the comparator and the candidate tests, a 15-minute waiting period to allow for viral reloading will occur before collecting the candidate test sample.

Trial Locations (3)

33144

Bright Research Center, Miami

37919

EDP Biotech, Knoxville

38125

PathAI, Memphis

All Listed Sponsors
collaborator

New Day Diagnostics

NETWORK

collaborator

PathAI

INDUSTRY

collaborator

Bright Research Center

INDUSTRY

lead

QuantuMDx Group Ltd

INDUSTRY